AlphaVax gets FDA OK for vaccine trials
The cytomegalovirus (CMV) alphavaccine, which contains three gene targets from CMV, will first be tested in healthy volunteers before being testing in target populations such as solid organ
The US Food and Drug Administration (FDA) has granted accelerated approval to Bristol Myers Squibb’s (BMS) Zenbexus (iberdomide), along with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd), to treat adult multiple myeloma (MM) patients.